Differential nitric oxide synthase expression during hepatic ischemia-reperfusion

被引:47
作者
Serracino-Inglott, F [1 ]
Virlos, IT
Habib, NA
Williamson, RCN
Mathie, RT
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Div Surg Anesthet & Intens Care, London, England
[2] N Manchester Grp Hosp, Dept Vasc Surg, Manchester M8 5RB, Lancs, England
关键词
nitric oxide; nitric oxide synthases; hepatic reperfusion injury;
D O I
10.1016/S0002-9610(03)00075-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: In recent years the important role of nitric oxide in hepatic ischemia-reperfusion injury has been increasingly recognised. The prevailing consensus is that reperfusion injury may be partly the result of decreased production of nitric oxide from endothelial nitric oxide synthase and excessive production of nitric oxide from the inducible isoform. We therefore undertook this study to characterize the expression of different nitric oxide synthase isoforms during hepatic reperfusion. Methods: Male Wistar rats (n = 6) were subjected to 45 minutes of partial hepatic ischemia (left lateral and median lobes) followed by 6 hours of reperfusion. Control animals (n = 6) were subjected to sham laparotomy. The expression of endothelial and inducible nitric oxide synthase was examined using inummohistochemistry and Western blotting. Liver sections were also stained with nitrotyrosine antibody, a specific marker of protein damage induced by peroxynitrite (a highly reactive free radical formed from nitric oxide). Results: Liver sections from all the control animals showed normal expression of the endothelial isoform and no expression of inducible nitric oxide synthase. Livers from all the animals subjected to hepatic ischemia showed decreased expression of endothelial nitric oxide synthase, and all but one animal from this group showed expression of the inducible isoform both in inflammatory cells and in hepatocytes. Western blotting confirmed these findings. Staining with the antinitrotyrosine antibody was also confined to five liver sections from animals subjected to hepatic ischemia. Conclusions: During the reperfusion period after hepatic ischemia, endothelial nitric oxide synthase is downregulated while inducible nitric oxide synthase is expressed in both hepatocytes and inflammatory cells. The presence of nitrotyrosine in livers subjected to hepatic ischemia-reperfusion suggests that the expression of inducible nitric oxide synthase plays an important role in mediating reperfusion injury in this model. (C) 2003 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 39 条
[1]  
[Anonymous], [No title captured]
[2]   ROLE OF NITRIC-OXIDE IN PORCINE LIVER CIRCULATION UNDER NORMAL AND ENDOTOXEMIC CONDITIONS [J].
AYUSE, T ;
BRIENZA, N ;
REVELLY, JP ;
BOITNOTT, JK ;
ROBOTHAM, JL .
JOURNAL OF APPLIED PHYSIOLOGY, 1995, 78 (04) :1319-1329
[3]   NITRIC-OXIDE, AN ENDOTHELIAL-CELL RELAXATION FACTOR, INHIBITS NEUTROPHIL SUPEROXIDE ANION PRODUCTION VIA A DIRECT ACTION ON THE NADPH OXIDASE [J].
CLANCY, RM ;
LESZCZYNSKAPIZIAK, J ;
ABRAMSON, SB .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :1116-1121
[4]  
COLETTI LM, 1996, HEPATOLOGY, V23, P506
[5]   Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat [J].
Cottart, CH ;
Do, L ;
Blanc, MC ;
Vaubourdolle, M ;
Descamps, G ;
Durand, D ;
Galen, FX ;
Clot, JP .
HEPATOLOGY, 1999, 29 (03) :809-813
[6]  
Davies MG, 1999, ISCHAEMIA-REPERFUSION INJURY, P157
[7]  
De C.R., 1995, J CLIN INVEST, V96, P60
[8]   VASCULAR OCCLUSIONS FOR LIVER RESECTIONS - OPERATIVE MANAGEMENT AND TOLERANCE TO HEPATIC ISCHEMIA - 142 CASES [J].
DELVA, E ;
CAMUS, Y ;
NORDLINGER, B ;
HANNOUN, L ;
PARC, R ;
DERIAZ, H ;
LIENHART, A ;
HUGUET, C .
ANNALS OF SURGERY, 1989, 209 (02) :211-218
[9]   Modulation of endothelin and nitric oxide: A rational approach to improve canine hepatic microcirculation [J].
Dhar, DK ;
Yamanoi, A ;
Ohmori, H ;
Nakashima, Y ;
Yamamoto, A ;
Osama, NE ;
Kubota, H ;
Kohno, H ;
Nagasue, N .
HEPATOLOGY, 1998, 28 (03) :782-788
[10]  
GELLER DA, 1995, J IMMUNOL, V155, P4890